Increasing studies have shown that the density of CD3+ and CD8+ lymphocyte populations in the tumor microenvironment could effectively predict the recurrence and metastasis of GC and complement the TNM staging system (34, 35). The gene discussed is CD8A; the disease is gastric cancer.